Search

Structure of the human UFC1 protein in complex with the UBA5 C-terminal UFC1-binding motif.
Authors
Wesch, W., Loehr, F., Rogova, N., Doetsch, V., Rogov, V.V.
Assembly
Ubiquitin-fold modifier-conjugating enzyme 1, Ubiquitin-like modifier-activating enzyme 5
Entity
1. Ubiquitin-fold modifier-conjugating enzyme 1, Ubiquitin-like modifier-activating enzyme 5, entity 1 (polymer), 167 monomers, 19458.14 Da Detail

MADEATRRVV SEIPVLKTNA GPRDRELWVQ RLKEEYQSLI RYVENNKNAD NDWFRLESNK EGTRWFGKCW YIHDLLKYEF DIEFDIPITY PTTAPEIAVP ELDGKTAKMY RGGKICLTDH FKPLWARNVP KFGLAHLMAL GLGPWLAVEI PDLIQKGVIQ HKEKCNQ


2. Ubiquitin-fold modifier-conjugating enzyme 1, Ubiquitin-like modifier-activating enzyme 5, entity 2 (polymer, Thiol state: not present), 27 monomers, 3032.441 Da Detail

GMSVTELTVE DSGESLEDLM AKMKNMW


Total weight
22490.582 Da
Max. entity weight
19458.14 Da
Source organism
Homo sapiens
Exptl. method
solution NMR
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 99.0 %, Completeness: 86.9 %, Completeness (bb): 80.9 % Detail

Polymer type: polypeptide(L)

Total1H13C15N
All86.9 % (2049 of 2357)95.4 % (1172 of 1228)74.3 % (679 of 914)92.1 % (198 of 215)
Backbone80.9 % (925 of 1144)95.9 % (374 of 390)65.6 % (374 of 570)96.2 % (177 of 184)
Sidechain93.3 % (1302 of 1395)95.2 % (798 of 838)91.8 % (483 of 526)67.7 % (21 of 31)
Aromatic81.3 % (169 of 208)91.3 % (95 of 104)69.1 % (67 of 97)100.0 % (7 of 7)
Methyl98.1 % (204 of 208)98.1 % (102 of 104)98.1 % (102 of 104)

1. entity 1

MADEATRRVV SEIPVLKTNA GPRDRELWVQ RLKEEYQSLI RYVENNKNAD NDWFRLESNK EGTRWFGKCW YIHDLLKYEF DIEFDIPITY PTTAPEIAVP ELDGKTAKMY RGGKICLTDH FKPLWARNVP KFGLAHLMAL GLGPWLAVEI PDLIQKGVIQ HKEKCNQ

2. entity 2

GMSVTELTVE DSGESLEDLM AKMKNMW

Sample #1

Solvent system 95% H2O/5% D2O, Pressure 1 (±0.01) atm, Temperature 298 (±0.2) K, pH 7.5 (±0.05), Details 1.0 mM [U-100% 13C; U-100% 15N] Ubiquitin-fold modifier-conjugating enzyme 1, 1.0 mM Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS, 95% H2O/5% D2O.


#NameIsotope labelingTypeConcentration
1Ubiquitin-fold modifier-conjugating enzyme 1[U-100% 13C; U-100% 15N]1.0 (±0.05) mM
2Ubiquitin-like modifier-activating enzyme 5natural abundance1.0 (±0.05) mM
3TRISnatural abundance50 (±1.0) mM
4sodium chloridenatural abundance100 (±1.0) mM
5TCEPnatural abundance2 (±0.1) mM
6AEBSF protease inhibitornatural abundance5 (±0.1) mM
7DSSnatural abundance0.15 (±0.01) mM
Sample #2

Solvent system 95% H2O/5% D2O, Pressure 1 (±0.01) atm, Temperature 298 (±0.2) K, pH 7.5 (±0.05), Details 1.2 mM Ubiquitin-fold modifier-conjugating enzyme 1, 0.3 mM [U-100% 13C; U-100% 15N] Ubiquitin-like modifier-activating enzyme 5, 50 mM TRIS, 100 mM sodium chloride, 2 mM TCEP, 5 mM AEBSF protease inhibitor, 0.15 mM DSS, 95% H2O/5% D2O.


#NameIsotope labelingTypeConcentration
8Ubiquitin-fold modifier-conjugating enzyme 1natural abundance1.2 (±0.05) mM
9Ubiquitin-like modifier-activating enzyme 5[U-100% 13C; U-100% 15N]0.3 (±0.05) mM
10TRISnatural abundance50 (±1.0) mM
11sodium chloridenatural abundance100 (±1.0) mM
12TCEPnatural abundance2 (±0.1) mM
13AEBSF protease inhibitornatural abundance5 (±0.1) mM
14DSSnatural abundance0.15 (±0.01) mM

Release date
2021-07-11
Citation
A Concerted Action of UBA5 C-Terminal Unstructured Regions Is Important for Transfer of Activated UFM1 to UFC1
Wesch, W., Loehr, F., Rogova, N., Doetsch, V., Rogov, V.V.
Int. J. Mol. Sci. (2021), 22, 7390-7390, PubMed 34299007 , DOI 10.3390/ijms22147390 ,
Related entities 1. Ubiquitin-fold modifier-conjugating enzyme 1, Ubiquitin-like modifier-activating enzyme 5, entity 1, : 1 : 13 entities Detail
Related entities 2. Ubiquitin-fold modifier-conjugating enzyme 1, Ubiquitin-like modifier-activating enzyme 5, entity 2, : 1 : 3 : 9 entities Detail
Interaction partners 2. Ubiquitin-fold modifier-conjugating enzyme 1, Ubiquitin-like modifier-activating enzyme 5, entity 2, : 19 interactors Detail
Experiments performed 16 experiments Detail
Chemical shift validation 4 contents Detail
Keywords LIGASE, UBA5, UFC1, UFM1, complex structure, ufmylation